https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
MALAT1 was found to upregulate IGF2BP2 and enhance MYC expression via m6A modification recognition by competitively binding to miR-204, conferring a stimulatory effect on proliferation, migration, and invasion of TC cells, which was accompanied by weakened tumor growth and cell apoptosis. Altogether, the central findings of our study suggest that MALAT1 contributes to TC progression through the upregulation of IGF2BP2 by binding to miR-204.Facioscapulohumeral dystrophy (FSHD) is characterized by a loss of repressive epigene
Aimer
Commentaire
Partagez
